Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-04-29

Clinical Trial Update: Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluated changes in brain neurochemistry in schizophrenia patients treated with quetiapine, using magnetic resonance spectroscopy t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (Seroquel) (quetiapine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED